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Background
• Osteoarthritis is the degeneration of articular cartilage and is clinically identified by pain that persists as well as
stiffness and disability.
• Patients with osteoarthritis have very few options for effective long-term treatment.
• Treatments such as pain medications, anti-inflammatories such as nonsteroidal anti-inflammatory drugs (NSAIDs), lubrication,
and surgery can only prolong but not cure osteoarthritis.

Embryonic Stem Cells
• Pluripotent- differentiate into all the cell types
that make up a body
• The process is very long and not cost-efficient
• Many regulations put in place by the
government on research conducted using
embryonically derived stem cells so that
pregnancy is not purposely terminated to
provide stem cells
• Most versatile type of stem cells

Mesenchymal Stem Cells
• Adult- derived stem cells
•

Can be derived from Adipose Tissue, bone
marrow, etc.

• Exhibit pluripotent properties
•

Useful alternative

• Easy and cost-efficient to derive from an adult
host
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Methods
• Stem cells derived from bone marrow from the same individual were
obtained and expanded.
• A safety test was then conducted on the stem cells that were
derived from the bone marrow prior to injection.
• All drugs were stopped 3-4 weeks prior to injection as a control and a
baseline was measured. Stem cells were then injected into the more
severely damaged knee.
• The Research Committee and the Ethical Committee of the Tehran
University of Medical Sciences reviewed this study for the inclusion of
human subjects and approved it based on the guidelines of the Helsinki
Declaration
• Results were collected after 6 months and a follow-up study was
conducted after 5 years
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Results
• Six months after the injection of stem cells, range of motion and
flexion of the knee showed significant improvement across all
four patients.
• However, five years after the injection the range of motion decreased
in comparison to six months after the treatment, but still remained
above the baseline.
• This is the second experiment ever done on human subjects, the first
was conducted by Centeno in 2008 and there was an improvement in
range of motion at 6 months but started to decline again at 12
months.
• There was also no long term follow up done after a few years to track
progression.

• Neither experiment caused any adverse side effects and showed an
overall improvement in the knee compared to the baseline.
• However, there are very few test subjects and multiple confounding variables
that could potentially affect the validity of this data as there are too many
regulations required to remain within the ethical guidelines.
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Discussion Questions
• How do you think stem cell research will change/ evolve in the future?
• Will scientists use embryonic stem cells and mesenchymal stem cells in
the future? Which do you think?
• Do you think mesenchymal stem cells will work as an alternative to
embryonic stem cells?
• Should regulations on embryonic stem cells should be lifted? Are they
justified?
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?

Links
Article link in VCU libraries
• https://vcu-alma-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_wj10.1111%2F1756185X.12670&context=PC&vid=VCUL&lang=en_US&search_scope=all_scope&adaptor=primo_central_multiple_fe&tab=
all&query=any,contains,Mesenchymal%20stem%20cell%20therapy%20for%20knee%20osteoarthritis:%205%20years%2
0follow-up%20of%20three%20patients

More information on embryonic stem cells
• https://stemcells.nih.gov/info/Regenerative_Medicine/2006Chapter1.htm
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